Hanna R, Miron I, Dalvi S, Arany P, Bensadoun R, Benedicenti S
Pharmaceuticals (Basel). 2024; 17(8).
PMID: 39204116
PMC: 11357434.
DOI: 10.3390/ph17081011.
Peters F, Raith S, Bock A, Kniha K, Ooms M, Mohlhenrich S
Head Face Med. 2024; 20(1):42.
PMID: 39135061
PMC: 11321092.
DOI: 10.1186/s13005-024-00444-y.
Taketomi T, Fukuda T, Nojiri J, Sanui T
Am J Case Rep. 2024; 25:e943807.
PMID: 39030674
PMC: 11304664.
DOI: 10.12659/AJCR.943807.
Alqarni H, Aldghim A, Alkahtani R, Alshahrani N, Altoman M, Alfaifi M
Saudi Dent J. 2024; 36(5):665-673.
PMID: 38766295
PMC: 11096620.
DOI: 10.1016/j.sdentj.2024.02.011.
Feng Z, An J, Zhang Y, He Y
Hua Xi Kou Qiang Yi Xue Za Zhi. 2024; 41(1):43-51.
PMID: 38596940
PMC: 9988446.
DOI: 10.7518/hxkq.2023.01.006.
Different Presentation and Outcomes in the Surgical Treatment of Advanced MRONJ in Oncological and Nononcological Patients Taking or Not Corticosteroid Therapy.
Garzino Demo P, Bojino A, Roccia F, Malandrino M, Cocis S, Ramieri G
Biomed Res Int. 2024; 2021:7855497.
PMID: 38523862
PMC: 10960651.
DOI: 10.1155/2021/7855497.
A clinical retrospective study of implant as a risk factor for medication-related osteonecrosis of the jaw: surgery vs loading?.
Kwon Y, Jo H, Kim J, Ohe J
Maxillofac Plast Reconstr Surg. 2023; 45(1):31.
PMID: 37707716
PMC: 10501104.
DOI: 10.1186/s40902-023-00398-2.
Multiple-Drugs-Related Osteonecrosis of the Jaw in a Patient Affected by Multiple Myeloma: A Case Report.
Caggiano M, Di Spirito F, Acerra A, Galdi M, Sisalli L
Dent J (Basel). 2023; 11(4).
PMID: 37185482
PMC: 10137621.
DOI: 10.3390/dj11040104.
Osteoradionecrosis of the Jaw-Comparison between Bone and Soft Tissue Injury and Their Influence on Surgical Outcomes-A Retrospective Cohort Study.
Ristow O, Birgel J, Ruckschloss T, Held T, Lang K, Smielowski M
Diagnostics (Basel). 2023; 13(3).
PMID: 36766471
PMC: 9914009.
DOI: 10.3390/diagnostics13030366.
Can topical phenytoin combined with tetracycline enhance the healing process in medication-related osteonecrosis of jaw? A comparative study.
Tabrizi R, Khiabani K, Shafiei S, Nosrati G, Moslemi H
Natl J Maxillofac Surg. 2022; 13(2):195-200.
PMID: 36051805
PMC: 9426693.
DOI: 10.4103/njms.njms_9_22.
Evaluation of advanced platelet-rich fibrin (PRF) as a bio-carrier for ampicillin/sulbactam.
Straub A, Vollmer A, Lam T, Brands R, Stapf M, Scherf-Clavel O
Clin Oral Investig. 2022; 26(12):7033-7044.
PMID: 35941396
PMC: 9708756.
DOI: 10.1007/s00784-022-04663-y.
[Management of medication-related osteonecrosis of the jaw-a review of recent study results in comparison to established strategies].
Troltzsch M, Troltzsch M, Pautke C, Otto S
HNO. 2022; 70(7):499-507.
PMID: 35050392
PMC: 9242957.
DOI: 10.1007/s00106-021-01130-0.
Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab.
Wick A, Bankosegger P, Otto S, Hohlweg-Majert B, Steiner T, Probst F
Clin Oral Investig. 2021; 26(3):2839-2852.
PMID: 34812959
PMC: 8898220.
DOI: 10.1007/s00784-021-04261-4.
Investigation of the Effectiveness of Surgical Treatment on Maxillary Medication-Related Osteonecrosis of the Jaw: A Literature Review.
Hsu K, Hsiao S, Chen P, Chen H, Chen C
J Clin Med. 2021; 10(19).
PMID: 34640498
PMC: 8509137.
DOI: 10.3390/jcm10194480.
Analysis of Factors Associated with the Postoperative Healing of Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis.
Shim Y, Jung S, Boboeva O, Lee S, Kim J, Kwon T
J Clin Med. 2021; 10(16).
PMID: 34441947
PMC: 8397037.
DOI: 10.3390/jcm10163651.
Surgical strategy for medication-related osteonecrosis of the jaw (MRONJ) on maxilla: A multicenter retrospective study.
Okuyama K, Hayashida S, Rokutanda S, Kawakita A, Soutome S, Sawada S
J Dent Sci. 2021; 16(3):885-890.
PMID: 34141102
PMC: 8189890.
DOI: 10.1016/j.jds.2020.12.007.
Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ).
Otto S, Aljohani S, Fliefel R, Ecke S, Ristow O, Burian E
Medicina (Kaunas). 2021; 57(5).
PMID: 34065104
PMC: 8151678.
DOI: 10.3390/medicina57050463.
Combined approach to treatment of advanced stages of medication-related osteonecrosis of the jaw patients.
Sahin O, Akan E, Tatar B, Ekmekcioglu C, Unal N, Odabasi O
Braz J Otorhinolaryngol. 2021; 88(4):613-620.
PMID: 34023243
PMC: 9422660.
DOI: 10.1016/j.bjorl.2021.04.004.
The awareness and practice of dentists regarding medication-related osteonecrosis of the jaw and its prevention: a cross-sectional survey.
Han A
BMC Oral Health. 2021; 21(1):155.
PMID: 33761923
PMC: 7992948.
DOI: 10.1186/s12903-021-01475-6.
On the effect of antiresorptive drugs on the bone remodeling of the mandible after dental implantation: a mathematical model.
Ashrafi M, Ghalichi F, Mirzakouchaki B, Doblare M
Sci Rep. 2021; 11(1):2792.
PMID: 33531628
PMC: 7854758.
DOI: 10.1038/s41598-021-82502-y.